Enantioselective inhibitory effect of nicardipine on the hepatic-clearance of propranolol in man.
- Author
- I VERCRUYSSE, Frans Belpaire, P WYNANT, DL MASSART and AG DUPONT
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-197511
- MLA
- VERCRUYSSE, I, Frans Belpaire, P WYNANT, et al. “Enantioselective Inhibitory Effect of Nicardipine on the Hepatic-clearance of Propranolol in Man.” CHIRALITY 6.1 (1994): 5–10. Print.
- APA
- VERCRUYSSE, I., Belpaire, F., WYNANT, P., MASSART, D., & DUPONT, A. (1994). Enantioselective inhibitory effect of nicardipine on the hepatic-clearance of propranolol in man. CHIRALITY, 6(1), 5–10.
- Chicago author-date
- VERCRUYSSE, I, Frans Belpaire, P WYNANT, DL MASSART, and AG DUPONT. 1994. “Enantioselective Inhibitory Effect of Nicardipine on the Hepatic-clearance of Propranolol in Man.” Chirality 6 (1): 5–10.
- Chicago author-date (all authors)
- VERCRUYSSE, I, Frans Belpaire, P WYNANT, DL MASSART, and AG DUPONT. 1994. “Enantioselective Inhibitory Effect of Nicardipine on the Hepatic-clearance of Propranolol in Man.” Chirality 6 (1): 5–10.
- Vancouver
- 1.VERCRUYSSE I, Belpaire F, WYNANT P, MASSART D, DUPONT A. Enantioselective inhibitory effect of nicardipine on the hepatic-clearance of propranolol in man. CHIRALITY. 1994;6(1):5–10.
- IEEE
- [1]I. VERCRUYSSE, F. Belpaire, P. WYNANT, D. MASSART, and A. DUPONT, “Enantioselective inhibitory effect of nicardipine on the hepatic-clearance of propranolol in man.,” CHIRALITY, vol. 6, no. 1, pp. 5–10, 1994.
@article{197511,
author = {VERCRUYSSE, I and Belpaire, Frans and WYNANT, P and MASSART, DL and DUPONT, AG},
issn = {0899-0042},
journal = {CHIRALITY},
language = {eng},
number = {1},
pages = {5--10},
title = {Enantioselective inhibitory effect of nicardipine on the hepatic-clearance of propranolol in man.},
volume = {6},
year = {1994},
}